Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
13.38
-0.01 (-0.07%)
Streaming Delayed Price
Updated: 10:46 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
34
35
Next >
Psychedelic Stock Gainers And Losers From November 21, 2022
↗
November 21, 2022
Via
Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
↗
November 20, 2022
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...
Via
Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
November 18, 2022
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
↗
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
November 15, 2022
Via
Benzinga
Mind Medicine’s Bad Trip Won’t End Anytime Soon
↗
November 04, 2022
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
↗
November 16, 2022
Upgrades
Via
Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
↗
November 15, 2022
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics
Via
Benzinga
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
November 14, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
↗
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
↗
November 11, 2022
Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022.
Via
Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
↗
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
↗
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
↗
November 07, 2022
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.
Via
Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
↗
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
↗
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
↗
November 03, 2022
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...
Via
Benzinga
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
November 03, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
↗
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
↗
October 28, 2022
While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities.
Via
InvestorPlace
October Recap: Major Psychedelic Drug Stocks Declined 9.9%
↗
October 27, 2022
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.
Via
Talk Markets
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 27, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
↗
October 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
↗
October 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39
Via
Benzinga
Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week
↗
October 24, 2022
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since...
Via
Talk Markets
Allied, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 21, 2022
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53
Via
Benzinga
Why Mind Medicine Zoomed 8% Higher on Tuesday
↗
October 18, 2022
The support for legalizing drugs -- such as those being studied by the company -- grows with a U.S. senator's tweet.
Via
The Motley Fool
Psychedelic Stock Gainers And Losers From October 18, 2022
↗
October 18, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
